Forecyte Biotechnologies

Maryland-based Contract Development and Manufacturing Organization (CDMO) Forecyte Biotechnologies has announced the opening of a new, state-of-the-art cell and gene therapy (CGT) GMP facility in Shanghai on March 31. This marks the company’s second facility, following the opening of a US-based facility in January. Investment and Global Impact of the…